Qualitative analysis of Adenomatous Polyposis Coli promoter: Hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Zare, Maryam ^a,b   Jazii, Ferdous Rastgar ^a   Alivand, Mohammad Reza ^a,b   Nasseri, Negin Karimi ^c   Malekzadeh, Reza ^d   Yazdanbod, Mansour ^e  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b Khatam University   (Iran)

^c UNIVERSITY OF TORONTO   (Canada)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BISULFITE; PRIMER DNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; ESOPHAGUS CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IRAN; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN METHYLATION; QUALITATIVE ANALYSIS; SURVIVAL RATE; DNA METHYLATION; ESOPHAGUS TUMOR; GENE AMPLIFICATION; GENETIC MARKER; GENETICS; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; DNA PRIMERS; ESOPHAGEAL NEOPLASMS; FEMALE; GENE AMPLIFICATION; GENES, APC; GENETIC MARKERS; HUMANS; IRAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; YOUNG ADULT;

EID: 60549105721     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-24     Document Type: Article

References (72)

1. Mosavi-Jarrahi A Mohagheghi MA Epidemiology of esophageal cancer in the high-risk population of iran Asian Pac J Cancer Prev 2006, 7(3):375-380 17059325
2. Mahboubi JKaE Esophageal Cancer in the Caspian Littoral of Iran: Initial Studies Science 1972, 175(4024):846-853 10.1126/science.175.4024.846 5008604
3. Saidi F Malekzadeh R Sotoudeh M Derakhshan MH Farahvash MJ Yazdanbod A Merat S Mikaeli J Sotoudehmanesh R Nasseri-Moghadam S et al Endoscopic esophageal cancer survey in the western part of the Caspian Littoral Dis Esophagus 2002, 15(3):214-218 10.1046/j.1442-2050.2002.00250.x 12444993
4. Saidi F Sepehr A Fahimi S Farahvash MJ Salehian P Esmailzadeh A Keshoofy M Pirmoazen N Yazdanbod M Roshan MK Oesophageal cancer among the Turkomans of northeast Iran Br J Cancer 2000, 83(9):1249-1254 10.1054/ bjoc.2000.1414 11027442
5. Munoz N Epidemiological aspects of oesophageal cancer Endoscopy 1993, 25(9):609-612 10.1055/s-2007-1010415 8119215
6. Blot WJ McLaughlin JK The changing epidemiology of esophageal cancer Semin Oncol 1999, 26(5 Suppl 15):2-8 10566604
7. Devesa SS Blot WJ Fraumeni JF Jr Changing patterns in the incidence of esophageal and gastric carcinoma in the United States Cancer 1998, 83(10):2049-2053 10.1002/ (SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2 9827707
8. Tabernero J Macarulla T Ramos FJ Baselga J Novel targeted therapies in the treatment of gastric and esophageal cancer Ann Oncol 2005, 16(11):1740-1748 10.1093/annonc/mdi355 15980157
9. Miyake S Nagai K Yoshino K Oto M Endo M Yuasa Y Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis Cancer Res 1994, 54(11):3007-3010 8187090
10. Sepehr A Taniere P Martel-Planche G Zia'ee AA Rastgar-Jazii F Yazdanbod M Etemad-Moghadam G Kamangar F Saidi F Hainaut P Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran Oncogene 2001, 20(50):7368-7374 10.1038/sj.onc.1204912 11704866
11. Boynton RF Blount PL Yin J Brown VL Huang Y Tong Y McDaniel T Newkirk C Resau JH Raskind WH et al Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers Proc Natl Acad Sci USA 1992, 89(8):3385-3388 48872 1565631 10.1073/ pnas.89.8.3385
12. Huang Y Boynton RF Blount PL Silverstein RJ Yin J Tong Y McDaniel TK Newkirk C Resau JH Sridhara R et al Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers Cancer Res 1992, 52(23):6525-6530 1423299
13. Mori T Aoki T Matsubara T Iida F Du X Nishihira T Mori S Nakamura Y Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus Cancer Res 1994, 54(7):1638-1640 7907942
14. Mori T Miura K Aoki T Nishihira T Mori S Nakamura Y Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma Cancer Res 1994, 54(13):3396-3397 8012957
15. Biramijamal F Allameh A Mirbod P Groene HJ Koomagi R Hollstein M Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran Cancer Res 2001, 61(7):3119-3123 11306496
16. Casson AG Mukhopadhyay T Cleary KR Ro JY Levin B Roth JA p53 gene mutations in Barrett's epithelium and esophageal cancer Cancer Res 1991, 51(16):4495-4499 1868473
17. Muzeau F Flejou JF Thomas G Hamelin R Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers Int J Cancer 1997, 72(1):27-30 10.1002/ (SICI)1097-0215(19970703)72:1<27::AID-IJC3>3.0.CO;2-6 9212218
18. Zhuang Z Vortmeyer AO Mark EJ Odze R Emmert-Buck MR Merino MJ Moon H Liotta LA Duray PH Barrett's esophagus: Metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma Cancer Res 1996, 56(9):1961-1964 8616831
19. Smith E De Young NJ Tian ZQ Caruso M Ruszkiewicz AR Liu JF Jamieson GG Drew PA Methylation of TIMP3 in esophageal squamous cell carcinoma World J Gastroenterol 2008, 14(2):203-210 10.3748/wjg.14.203 18186556
20. Guo M Ren J House MG et al Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus Clin Cacer Res 2006, 12:4515-4522 10.1158/1078-0432.CCR-05-2858
21. Park HL Kim MS Yamashita K Westra W Carvalho AL Lee J Jiang WW Baek JH Liu J Osada M et al DCC promoter hypermethylation in esophageal squamous cell carcinoma International journal of cancer 2008, 122(11):2498-2502 10.1002/ijc.23434
22. Lee EJ Lee BB Han J et al CpG island hypermethylation of E-cadherin (CDH1) and integrin 4 is associated with recurrence of early stage esophageal squamous cell carcinoma International journal of cancer 2008, 123(9):2073-2079 10.1002/ijc.23598
23. Brock MV Gou M Akiyama Y Muller A Wu TT Montgomery E Deasel M Germonpre P Rubinson L Heitmiller RF et al Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma Clin Cancer Res 2003, 9(8):2912-2919 12912936
24. Eads CA Lord RV Wickramasinghe K Long TI Kurumboor SK Bernstein L Peters JH DeMeester SR DeMeester TR Skinner KA et al Epigenetic patterns in the progression of esophageal adenocarcinoma Cancer Res 2001, 61(8):3410-3418 11309301
25. Ishii T Murakami J Notohara K Cullings HM Sasamoto H Kambara T Shirakawa Y Naomoto Y Ouchida M Shimizu K et al Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa Gut 2007, 56(1):13-19 10.1136/gut.2005.089813 16785283
26. Jin Z Mori Y Yang J Sato F Ito T Cheng Y Paun B Hamilton JP Kan T Olaru A et al Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma Oncogene 2007, 26(43):6332-6340 10.1038/sj.onc.1210461 17452981
27. Tycko B Epigenetic gene silencing in cancer J Clin Invest 2000, 105(4):401-407 289180 10683367 10.1172/JCI9462
28. Brabender J Usadel H Danenberg KD Metzger R Schneider PM Lord RV Wickramasinghe K Lum CE Park J Salonga D et al Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival Oncogene 2001, 20(27):3528-3532 10.1038/ sj.onc.1204455 11429699
29. Brock MV Hooker CM Ota-Machida E Han Y Guo M Ames S Glockner S Piantadosi S Gabrielson E Pridham G et al DNA methylation markers and early recurrence in stage I lung cancer The New England journal of medicine 2008, 358(11):1118-1128 10.1056/NEJMoa0706550 18337602
30. Ellinger J El Kassem N Heukamp LC Matthews S Cubukluoz F Kahl P Perabo FG Muller SC von Ruecker A Bastian PJ Hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer The Journal of urology 2008, 179(1):346-352 10.1016/j.juro.2007.08.091 18006010
31. Karpinski P Sasiadek MM Blin N Aberrant epigenetic patterns in the etiology of gastrointestinal cancers Journal of applied genetics 2008, 49(1):1-10 18263964
32. Kawakami K Brabender J Lord RV Groshen S Greenwald BD Krasna MJ Yin J Fleisher AS Abraham JM Beer DG et al Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma J Natl Cancer Inst 2000, 92(22):1805-1811 10.1093/jnci/92.22.1805 11078757
33. Bektas N Donner A Wirtz C Heep H Gabbert HE Sarbia M Allelic loss involving the tumor suppressor genes APC and MCC and expression of the APC protein in the development of dysplasia and carcinoma in Barrett esophagus American journal of clinical pathology 2000, 114(6):890-895 10.1309/L1Q3-E3AQ-APU9-NA0A 11338478
34. Wang M Lu R Fang D [The possible role of loss of heterozygosity at APC, MCC and DCC genetic loci in esophageal carcinoma] Zhonghua Zhong Liu Za Zhi 1999, 21(1):16-18 11776787
35. Li H Lu S [Mutation of tumor suppressor genes APC and MCC in human esophageal cancer] Zhonghua zhong liu za zhi [Chinese journal of oncology] 1995, 17(1):9-12 7656796
36. Stoltzing O Schneider PM Becker K Wegerer S Siewert JR Holscher AH [Frequency and significance of APC gene mutations in malignant degeneration of Barrett esophagus] Langenbecks Arch Chir Suppl Kongressbd 1998, 115(Suppl I):485-489
37. Choi YW Heath EI Heitmiller R Forastiere AA Wu TT Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas Mod Pathol 2000, 13(10):1055-1059 10.1038/modpathol.3880194 11048797
38. Ogasawara S Maesawa C Tamura G Satodate R Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas Virchows Arch 1994, 424(6):607-611 10.1007/BF01069740 8055154
39. Powell SM Papadopoulos N Kinzler KW Smolinski KN Meltzer SJ APC gene mutations in the mutation cluster region are rare in esophageal cancers Gastroenterology 1994, 107(6):1759-1763 7958689
40. Rocheleau CE Downs WD Lin R Wittmann C Bei Y Cha YH Ali M Priess JR Mello CC Wnt signaling and an APC-related gene specify endoderm in early C. elegans embryos Cell 1997, 90(4):707-716 10.1016/ S0092-8674(00)80531-0 9288750
41. Morin PJ Sparks AB Korinek V Barker N Clevers H Vogelstein B Kinzler KW Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC Science 1997, 275(5307):1787-1790 10.1126/ science.275.5307.1787 9065402
42. Clement G Braunschweig R Pasquier N Bosman FT Benhattar J Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus Oncogene 2006, 25(21):3084-3092 10.1038/sj.onc.1209338 16407829
43. Wolff RK Frazer KA Jackler RK Lanser MJ Pitts LH Cox DR Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors Am J Hum Genet 1992, 51(3):478-485 1682717 1496981
44. Herman JG Jen J Merlo A Baylin SB Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B Cancer Res 1996, 56(4):722-727 8631003
45. John SW Weitzner G Rozen R Scriver CR A rapid procedure for extracting genomic DNA from leukocytes Nucleic Acids Res 1991, 19(2):408 333617 2014181 10.1093/nar/19.2.408
46. Olek A Oswald J Walter J A modified and improved method for bisulphite based cytosine methylation analysis Nucleic Acids Res 1996, 24(24):5064-5066 146326 9016686 10.1093/nar/24.24.5064
47. Engemann S El-Maarri O Hajkova P Oswald J Walter J Bisulfite-based methylation analysis of imprinted genes Methods Mol Biol 2001, 181:217-228 12843453
48. Grunau C Clark SJ Rosenthal A Bisulfite genomic sequencing: Systematic investigation of critical experimental parameters Nucleic Acids Res 2001, 29(13):E65-65 55789 11433041 10.1093/nar/29.13.e65
49. Herman JG Graff JR Myohanen S Nelkin BD Baylin SB Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 1996, 93(18):9821-9826 38513 8790415 10.1073/pnas.93.18.9821
50. Hube F Reverdiau P Iochmann S Gruel Y Improved PCR method for amplification of GC-rich DNA sequences Molecular biotechnology 2005, 31(1):81-84 10.1385/MB:31:1:081 16118416
51. Nagai M Yoshida A Sato N Additive effects of bovine serum albumin, dithiothreitol, and glycerol on PCR Biochemistry and molecular biology international 1998, 44(1):157-163 9503159
52. Roux KH Optimization and troubleshooting in PCR PCR methods and applications 1995, 4(5):S185-194 7580907
53. Raja S Godfrey TE Luketich JD The role of tumor suppressor genes in esophageal cancer Minerva chirurgica 2002, 57(6):767-780 12592219
54. Eads CA Lord RV Kurumboor SK Wickramasinghe K Skinner ML Long TI Peters JH DeMeester TR Danenberg KD Danenberg PV et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma Cancer Res 2000, 60(18):5021-5026 11016622
55. Tarmin L Yin J Zhou X Suzuki H Jiang HY Rhyu MG Abraham JM Krasna MJ Cottrell J Meltzer SJ Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus Cancer Res 1994, 54(23):6094-6096 7954453
56. Xing EP Nie Y Wang LD Yang GY Yang CS Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China Carcinogenesis 1999, 20(1):77-84 10.1093/carcin/ 20.1.77 9934853
57. Xing EP Yang GY Wang LD Shi ST Yang CS Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer Clin Cancer Res 1999, 5(5):1231-1240 10353761
58. Esteller M Epigenetic gene silencing in cancer: The DNA hypermethylome Human molecular genetics 2007, 16(Spec No 1):R50-59 10.1093/hmg/ddm018 17613547
59. Michor F Iwasa Y Lengauer C Nowak MA Dynamics of colorectal cancer Seminars in cancer biology 2005, 15(6):484-493 10.1016/ j.semcancer.2005.06.005 16055342
60. Kang GH Lee S Kim JS Jung HY Profile of aberrant CpG island methylation along multistep gastric carcinogenesis Laboratory investigation; a journal of technical methods and pathology 2003, 83(4):519-526 12695555
61. Takahashi T Shigematsu H Shivapurkar N Reddy J Zheng Y Feng Z Suzuki M Nomura M Augustus M Yin J et al Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers International journal of cancer 2006, 118(4):924-931 10.1002/ijc.21453
62. Laird PW Jackson-Grusby L Fazeli A Dickinson SL Jung WE Li E Weinberg RA Jaenisch R et al Suppression of intestinal neoplasia by DNA hypomethylation Cell 1995, 81(2):197-205 10.1016/0092-8674(95)90329-1 7537636
63. Clément G Fontolliet C Pasquier N et al APC, hTERT and TIMP-3: New molecular markers to distinguish patients at risk for the development of Barrett's esophageal adenocarcinoma Proc Amer Assoc Cancer Res 2004, 45
64. Smeds J Berggren P Ma X Xu Z Hemminki K Kumar R Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: The CDKN2A (p16(INK4a) and p14(ARF)) and p53 genes are major targets for inactivation Carcinogenesis 2002, 23(4):645-655 10.1093/carcin/23.4.645 11960918
65. Metzger R Schneider PM Warnecke-Eberz U Brabender J Holscher AH Molecular biology of esophageal cancer Onkologie 2004, 27(2):200-206 10.1159/000076913 15138356
66. Hu N Huang J Emmert-Buck MR Tang ZZ Roth MJ Wang C Dawsey SM Li G Li WJ Wang QH et al Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China Clin Cancer Res 2001, 7(4):883-891 11309337
67. Sherr CJ Principles of tumor suppression Cell 2004, 116(2):235-246 10.1016/S0092-8674(03)01075-4 14744434
68. Nie Y Liao J Zhao X Song Y Yang GY Wang LD Yang CS Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma Carcinogenesis 2002, 23(10):1713-1720 10.1093/carcin/ 23.10.1713 12376481
69. Lambertz S Ballhausen WG Identification of an alternative 5′ untranslated region of the adenomatous polyposis coli gene Hum Genet 1993, 90(6):650-652 10.1007/BF00202484 8383094
70. Zysman M Saka A Millar A Knight J Chapman W Bapat B Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype Cancer Res 2002, 62(13):3663-3666 12097272
71. Esteller M Sparks A Toyota M Sanchez-Cespedes M Capella G Peinado MA Gonzalez S Tarafa G Sidransky D Meltzer SJ et al Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer Cancer Res 2000, 60(16):4366-4371 10969779
72. Tsuchiya T Tamura G Sato K Endoh Y Sakata K Jin Z Motoyama T Usuba O Kimura W Nishizuka S et al Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia Oncogene 2000, 19(32):3642-3646 10.1038/sj.onc.1203704 10951570